TABLE 5.
Recurrence rates and follow up for SE
| REFERENCE | F/U DURATION | RECURRENCE RATE | PATIENT NUMBER | PROGRESSION TO LMM | PRE-OP | POST-OP |
|---|---|---|---|---|---|---|
| Bub et al19 | 57 months | 5% | 62 | 5% | 2.1 x 1.5 | 3.3 x 2.5 |
| Walling14 | 95 months | 7.3% | 41 | Not reported | 1.5 x 0.2 | 7.1 x 1.0 |
| Bosbous24 | 2.25 years | 1.7% | 59 | 10% | 1.5 x 1.4 | 3.4 x 3.1 |
| Current study | 138 months | 5.9% | 68 | Not reported | 1.5 ± 0.2cm2 | 8.1cm2 |
| Johnson25 | Not reported | 0% | 35 | Not reported | Not reported | Not reported |
| Hill and Gramp31 | 25 months | 1/66 | 66 | 32% | 23mm | 34mm |
| Zitelli8 | 5 years | 0.5% (LM data not addressed) | 553 | Not reported | Not reported* | Not reported* |
| Bhardwaj7 | 38.4 months | 0% | 200 | Not reported | 6.4cm2 | 16.4cm2 |
| Bene10 | 50 months | 1% | 116 | Not reported | Not reported | Not reported |
| Temple29 | 29.8 months | 0 | 153 | Not reported | Not reported | 11.8cm2 |
| Bricca15 | 58 months | 0.3% (LM data not addressed) | 625 | Not reported | N/A*+ | N/A*+ |
| Cohen13 | 58 months | 3% | 45 | none | 1.7 x 1.7 | 4.2 x 4.5 |
| Malhotra30 | 32 months | 3% | 141 | None | None | None |
| Robinson28 | 8 years | 6% | 16 | N/A | N/A | N/A |
| Abdelmalek et al20 | 32 months | 1.7% | 293 | Not reported | Not reported | Not reported |
| Huilgol et al26 | 38 months | 2% | 161 | Not reported | Not reported | Not reported |
| Möller et al23 | 14 months | 0% | 61 | 7.2cm2 | ||
| Gaudy-Marquestet al32 | 25.4 months | 4.76% | 21 | 27.5cm2 | ||
| Hazan et al22 | Not reported | Not reported | 117 | Not reported | LM: 11.3mm Lmm: 14.6mm | Not reported |
| Zalla et al27 | 16 months | 0% | 68 | Not reported | Not reported | Not reported |
27 included invasive melanoma
*
9mm margin cleared 95% of melanomas
+
did not specifically evaluate LM/LMM